NexImmune, Inc.
NEXIDelisted Sep 6, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001538210
NexImmune, Inc. was delisted on Sep 6, 2024; its insiders filed their last Form 4 on Jun 13, 2024; 13 institutions reported holding it in 13F filings for Q2 2024, worth $408.6K in total; no superinvestor held it.
Q4 2023 vs. Q3 2023
How the institutions holding NexImmune, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 31 | 11 | −20 |
| SharesConverted for a 1-for-25 split | 175.8K | 103.5K | −72.4K (−41.2%) |
| Value | $921.4K | $229.4K | −$692.0K (−75.1%) |
New holders (0)
Institutions that held NexImmune, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
None.
Sold out (20)
Institutions that held NexImmune, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Allen Operations LLC | 635,934 | $133.5K |
| Raymond James & Associates | 320,622 | $67.3K |
| First Manhattan Co | 149,110 | $31.3K |
| M28 Capital Management LP | 133,442 | $28.0K |
| CAPROCK Group, Inc. | 103,482 | $21.7K |
| Geode Capital Management, LLC | 108,143 | $21.6K |
| Vanguard Group Inc | 97,320 | $20.4K |
| Renaissance Technologies LLC | 65,500 | $14.0K |
| Bridgeway Capital Management, LLC | 50,000 | $10.0K |
| Millennium Management LLC | 46,660 | $9.33K |
| Bank of Montreal | 32,000 | $8.18K |
| Susquehanna International Group, LLP | 35,421 | $7.08K |
| Two Sigma Securities, LLC | 21,845 | $4.58K |
| State Street Corp | 22,919 | $4.58K |
| Baader Bank INC | 17,251 | $3.23K |
| Northern Trust Corp | 12,668 | $2.66K |
| Two Sigma Investments, LP | 10,077 | $2.12K |
| Smith, Salley & Associates | 10,000 | $2.10K |
| Advisor Group Holdings, Inc. | 1,000 | $210 |
| Qube Research & Technologies Ltd | 4 | $1 |